Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary Chronimed Awarded Sole Source Blood Glucose Test Strip Contract By Beverly Enterprises
Two-year agreement allows for distribution of blood glucose monitors and related products MINNEAPOLIS, November 1, 1999 -- Chronimed Inc. (Nasdaq: CHMD), announced today that it received a sole source contract from Fort Smith, AR-based Beverly Enterprises, Inc.
Toggle Summary Chronimed Reports Fiscal 2000 First Quarter Results
Click here for a printable version in PDF   NEWS RELEASE October 27, 1999 Contacts:  Paul S. Dunn, Investor Relations, or Maurice R. Taylor, II, Chairman and CEO, at Chronimed Inc. (612) 979-3600 CHRONIMED REPORTS FISCAL 2000 FIRST QUARTER RESULTS Company Reports Record Revenue and Improved
Toggle Summary Chronimed To Manage Fda Clinical Trials For Visible Genetics' Hiv Genotyping Test
MINNEAPOLIS, October 13, 1999 -- Chronimed Inc. (Nasdaq: CHMD), announced today that it has signed a contract with Visible Genetics Inc. (Nasdaq:VGIN) whereby Chronimed's wholly-owned subsidiary, Clinical Partners, will manage Visible Genetics' prospective multi-center, controlled clinical trial of
Toggle Summary Chronimed Reports Fiscal 1999 Fourth Quarter And Year End Results
MINNEAPOLIS, August 10, 1999 -- Chronimed Inc. (Nasdaq: CHMD),today announced fourth quarter and year end results for the period ended July 2, 1999. For the fourth quarter, Chronimed reported record revenue of $55.3 million, up 36 percent from $40.5 million last year.
Toggle Summary Chronimed Selected To Provide Transplant Medication Management Program For Prudential Healthcare Members
MINNEAPOLIS, June 16, 1999 -- Chronimed Inc. (Nasdaq: CHMD) announced today that Prudential HealthCare has selected the Chronimed Life Management Program SM to manage the medication regimens of its approximately 4,000 current transplant members and all future members who receive transplants.
Toggle Summary Chronimed Selected To Provide Transplant Medication Management Program For Prudential Healthcare Members
MINNEAPOLIS, June 16, 1999 -- Chronimed Inc. (Nasdaq: CHMD) announced today that Prudential HealthCare has selected the Chronimed Life Management Program SM to manage the medication regimens of its approximately 4,000 current transplant members and all future members who receive transplants.
Toggle Summary Chronimed Selected To Provide Transplant Medication Management Program For Prudential Healthcare Members
Chronimed Selected To Provide Transplant Medication Management Program For Prudential Healthcare Members MINNEAPOLIS, June 16, 1999 -- Chronimed Inc. (Nasdaq: CHMD) announced today that Prudential HealthCare has selected the Chronimed Life Management Program SM to manage the medication regimens of
Toggle Summary Chronimed Renews HIV Disease Management Contract With Blue Shield Of California
Contract Renewal Extends Relationship To Fourth Year MINNEAPOLIS, May 6, 1999 -- Chronimed Inc. (Nasdaq: CHMD), announced today that its wholly-owned subsidiary, Clinical Partners, signed a contract extension to perform HIV disease management with Blue Shield of California; the contract extends the
Toggle Summary Chronimed Renews HIV Disease Management Contract With Blue Shield Of California
Contract Renewal Extends Relationship To Fourth Year MINNEAPOLIS, May 6, 1999 -- Chronimed Inc. (Nasdaq: CHMD), announced today that its wholly-owned subsidiary, Clinical Partners, signed a contract extension to perform HIV disease management with Blue Shield of California; the contract extends the
Toggle Summary Chronimed Announces Third Quarter Fiscal 1999 Results
Also Announces Engagement of Paine Webber to Explore Strategic Alternatives MINNEAPOLIS, April 27, 1999 -- Chronimed Inc. (Nasdaq: CHMD), today announced third quarter revenue and net income for the period ended April 2, 1999. Chronimed reported record revenue for the third quarter ended April 2,